Article
AI platform for CRISPR functional mapping and function-based drug design
2026-05-11
Abstract excerpt
Conventional structure-based drug design has high clinical failure rates due to the disconnect where binding affinity does not guarantee safe functional modulation. To bridge this gap, we present CRISPRtile, a cloud-based platform for function-based drug design. By deriving library coverage optimization equations and leveraging AI to correct CRISPR guide biases, we generated toxicity and functional landscapes with...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c52506de-7b85-5766-addd-25999eb4f1c0
- DOI
- 10.64898/2026.05.06.722817
